Abstract: Novel protease variants derived from the DNA sequences of naturally-occurring or recombinant non-human proteases are disclosed. The variant proteases, in general, are obtained by in vitro modification of a precursor DNA sequence encoding the naturally-occurring or recombinant protease to generate the substitution of a plurality of amino acid residues in the amino acid sequence of a precursor protease. Such variant proteases have properties which are different from those of the precursor protease, such as altered wash performance. The substituted amino acid residue correspond to positions 62, 212, 230, 232, 252 and 257 of Bacillus amyloliquefaciens subtilisin.

Abstract: Novel protease variants derived from the DNA sequences of naturally-occurring or recombinant non-human proteases are disclosed. The variant proteases, in general, are obtained by in vitro modification of a precursor DNA sequence encoding the naturally-occurring or recombinant protease to generate the substitution of a plurality of amino acid residues in the amino acid sequence of a precursor protease. Such variant proteases have properties which are different from those of the precursor protease, such as altered wash performance.

Abstract: Novel protease variants derived from the DNA sequences of naturally-occurring or recombinant non-human proteases are disclosed. The variant proteases, in general, are obtained by in vitro modification of a precursor DNA sequence encoding the naturally-occurring or recombinant protease to generate the substitution of a plurality of amino acid residues in the amino acid sequence of a precursor protease. Such variant proteases have properties which are different from those of the precursor protease, such as altered wash performance. The substituted amino acid residue correspond to positions 62, 212, 230, 232, 252 and 257 of Bacillus amyloliquefaciens subtilisin.

Abstract: Novel protease variants derived from the DNA sequences of naturally-occurring or recombinant non-human proteases are disclosed. The variant proteases, in general, are obtained by in vitro modification of a precursor DNA sequence encoding the naturally-occurring or recombinant protease to generate the substitution of a plurality of amino acid residues in the amino acid sequence of a precursor protease. Such variant proteases have properties which are different from those of the precursor protease, such as altered wash performance.

Abstract: Novel protease variants derived from the DNA sequences of naturally-occurring or recombinant non-human proteases are disclosed. The variant proteases, in general, are obtained by in vitro modification of a precursor DNA sequence encoding the naturally-occurring or recombinant protease to generate the substitution of a plurality of amino acid residues in the amino acid sequence of a precursor protease. Such variant proteases have properties which are different from those of the precursor protease, such as altered wash performance. The substituted amino acid residue correspond to positions 62, 212, 230, 232, 252 and 257 of Bacillus amyloliquefaciens subtilisin.

Abstract: Novel protease variants derived from the DNA sequences of naturally-occurring or recombinant non-human proteases are disclosed. The variant proteases, in general, are obtained by in vitro modification of a precursor DNA sequence encoding the naturally-occurring or recombinant protease to generate the substitution of a plurality of amino acid residues in the amino acid sequence of a precursor protease. Such variant proteases have properties which are different from those of the precursor protease, such as altered wash performance.

Abstract: The present invention concerns cellulase-containing granular detergent compositions which are in a "compact" form, i.e. they are of a relatively high density and contain a relatively low amount of inorganic filler salt compared to conventional detergent compositions. In the detergent compositions herein the cellulase is defined by the C14CMC method described herein and preferably comprises a specific single-component endoglucanase.

Abstract: The present invention relates to detergent compositions comprising a high activity cellulase in combination with a softening clay. In the detergent compositions herein, the cellulase comprises a cellulase of high activity defined by the C14CMC-method. Preferably the detergent composition comprises a softening clay together with a clay flocculating agent and in case of liquid composition an anti-settling agent for the clay.

Abstract: Fabric conditioning compositions are disclosed which comprise, as a fabric softening ingredient, a fabric softening clay. The fabric softening clay is a hectorite of natural origin, and has a layer change distribution such that at least 50% is in the range 0.23-0.31. The clays exhibit high relative deposition values.

Abstract: Detergent compositions are disclosed which comprise, as a fabric softening ingredient, a fabric softening clay. The fabric softening clay is a hectorite of natural origin, having a layer change distribution such that at least 50% is in the range 0.23-0.31. The clays preferably exhibit Relative Deposition values of at least 2.5.

Abstract: The invention concerns the use of a concentrated granular detergent composition having a density of about 800 g/L or more comprising enzyme granulates characterized in that said enzyme granulates are present at a level of less than 20 g/L detergent composition, wherein said enzyme granulates have no negative impact on the whiteness of the detergent composition. Furthermore the invention relates to a concentrated granular detergent enzyme granulates characterized in that the concentration of high alkaline protease in the enzyme granulate is at least 2%.